• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FRESENIUS MEDICAL CARE NORTH AMERICA FMC BLOODLINES; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FRESENIUS MEDICAL CARE NORTH AMERICA FMC BLOODLINES; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Device Problems Occlusion Within Device (1423); Increase in Pressure (1491)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/27/2016
Event Type  malfunction  
Manufacturer Narrative
(b)(4).No parts were returned to the manufacturer for physical evaluation.The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
A home hemodialysis nurse reported an incident of blood loss experienced by a (b)(6) female end stage renal disease (esrd) patient receiving at home hemodialysis (hd) treatments.The patient was attempting to initialize the hd treatment, but stated that high venous pressure issues were encountered and were not easily cleared.The system passed all self-tests, however, the venous pressure was noted as being too high (260mmhg).The patient released the pressure from the medication port, and then placed the system into recirculation while blood was in the circuit, in an attempt to stabilize the venous pressure.The unit¿s transmembrane pressure (tmp) readings climbed from 150mmhg to 300mmhg.At the same time, the patient noted that the ¿s¿ clamp on the saline line was not closed, which resulted in blood backing up into the saline bag.Treatment was halted and the blood within the circuit was not returned.The patient proceeded to remove the needles from the access site, and noticed that the venous needle was dislodged.A second attempt was made to set up the machine, however, the machine failed to prime; no saline would circulate through the lines.The patient's doctor administered a hemoglobin (hgb) laboratory test and found the patient's hgb dropped from 111 to 105.The patient¿s estimated blood loss (ebl) was noted as being approximately 250cc, which was the amount lost due to not returning the blood within the extra corporeal circuit.No patient adverse effects were experienced and no medical intervention was required as a result of this event.The patient was reportedly anxious due to the blood loss, but had no other symptoms.An on-site evaluation of the 2008k at home machine was performed by a fresenius regional equipment specialist (res); no malfunction observed or identified during this testing.The tmp and venous pressures were checked; no issues identified.The complaint device is not available for evaluation by the manufacturer as it was discarded by the patient at the time of the event.
 
Manufacturer Narrative
The device was not returned to the manufacturer for physical evaluation, and the lot number was not provided.Therefore, the failure mode cannot be confirmed.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.A manufacturing review was performed of the products shipped to the dialysis center for the three (3) month time frame which immediately preceded the event occurrence date.This review included the lot numbers for all fresenius dialyzers shipped to this account within the selected time frame.A records review was performed on all lots identified.An investigation of the device manufacturing records was conducted by the manufacturer.There were no deviations or non-conformances identified during the manufacturing process which could be associated with the reported event.In addition, the batch record review confirmed the labeling, material, and process controls were within specification.The lots passed all release criteria.A review of the batch production records did not reveal a probable cause for the customer complaint.There were no non-conformances identified that relate to the reported event, and all lots met release criteria.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FMC BLOODLINES
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
FRESENIUS MEDICAL CARE NORTH AMERICA
mike allen #1331
parque industrial reynosa
reynosa, tamaulipas cp 88780
MX  88780
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa, tamaulipas cp 88780
MX   88780
Manufacturer Contact
tanya taft
920 winter st.
waltham, MA 02451
7816999000
MDR Report Key5741403
MDR Text Key48715721
Report Number8030665-2016-00300
Device Sequence Number1
Product Code FJK
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K070049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 07/21/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/22/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/27/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age56 YR
Patient Weight68
-
-